SCHEMBL24915568

SCHEMBL24915568

COc1cc(C(=O)Nc2n[nH]c(=O)o2)c2nc(C)cc(C(C)C)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 2/20 0.36
MTNR1B P49286 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
CD38 P28907 1/20 0.33
HTT P42858 1/20 0.33
MTNR1A P48039 1/20 0.32
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 2/20 0.32
RECQL P46063 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NOTUM Q6P988 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
ELANE P08246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915570 0.83 CSNK2A2 (0.39) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL24915921 0.80 MTNR1A (0.43) KDM4EALDH1A1MAPTHPGDCD38
SCHEMBL24915560 0.78 PIK3CA (0.50) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL24916230 0.76 SCN9A (0.36) KDM4EALDH1A1MAPTHPGDCD38
SCHEMBL24916058 0.76 KDM4E (0.50) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL24915923 0.75 CD38 (0.45) KDM4EALDH1A1HPGDCD38POLB
SCHEMBL24915919 0.72 HPGD (0.43) KDM4EALDH1A1MAPTHPGDMAOB
SCHEMBL24915573 0.71 KMT2A (0.43) KDM4EALDH1A1HPGDKMT2AHSD17B10
SCHEMBL24915974 0.67 KMT2A (0.40) MAPTMEN1KMT2APOLB
SCHEMBL24916052 0.63 P2RX3 (0.37) KDM4EALDH1A1MAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 KDM4E 105/4885ALDH1A1 3815/4885MTNR1B 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.